Overlapping syndrome of anti-MOG antibody-associated disease and anti-mGluR5 encephalitis manifested as optic neuritis: A case report
Jianhang He,Xiaoyan Niu,Xiaoyan Chen,Boya Ma,Yazhou Ren,Weimin Qi,Xiuping Zhan,Yue Meng,Jianxia Li,Haining Li
DOI: https://doi.org/10.1097/md.0000000000039146
IF: 1.6
2024-08-19
Medicine
Abstract:Myelin oligodendrocyte glycoprotein (MOG) is a myelin glycoprotein specifically expressed in the oligodendrocytes of the central nervous system. [ 1 ] Degradation and demyelination of oligodendrocytes is the result of activation of the complement cascade by anti-MOG antibodies. [ 2 ] MOG-associated disease (MOGAD), a novel autoimmune disorder, primarily presents itself as central nervous system (CNS) demyelination. The primary clinical manifestations include optic neuritis, transverse myelitis, brainstem demyelination, and acute disseminated encephalomyelitis. [ 3 ] Metabotropic glutamate receptor 5 (mGluR5) is a type of G-protein coupled receptors that is activated by binding to the excitatory neurotransmitter glutamate. Anti-mGluR5 encephalitis is an unusual and complex autoimmune disorder that affects the nervous system. To date, only 20 cases have been reported worldwide. Anti-mGluR5 encephalitis is characterized by cognitive impairment, psychiatric disturbances, seizures, disturbance of consciousness, and sleep disorders. Notably, the literature suggests mGluR5's role in guiding the differentiation of oligodendrocyte precursors into mature oligodendrocytes, which may elucidate the concurrent incidence of mGluR5 and MOG. [ 4 ] So far, MOG and mGluR5 double antibody positive encephalitis characterized by optic neuritis is extremely rare. Here, we present a case of overlapping syndrome of MOG-IgG-associated disease and anti-mGluR5 encephalitis manifested as optic neuritis. The purpose of this study is to enrich the extant literature and provide a reference for the clinical diagnosis and treatment of overlapping syndromes.
medicine, general & internal